This is a Validated Antibody Database (VAD) review about pig CDH2, based on 118 published articles (read how Labome selects the articles), using CDH2 antibody in all methods. It is aimed to help Labome visitors find the most suited CDH2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CDH2 synonym: cadherin-2; cadherin 2, type 1, N-cadherin (neuronal)

Invitrogen
mouse monoclonal (3B9)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3a
In order to examine connexin40 and connexin43 expression in mouse models of hypoxia and sleep apnea, Invitrogen CDH2 antibody (Life Technologies, 33-3900) was used in immunohistochemistry on mouse samples at 1:200 (fig 3a). BMC Cell Biol (2017) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:300
  • immunocytochemistry; human; 1:200; loading ...; fig 1c
  • western blot; human; 1:1000; loading ...; fig 1e
In order to test if chemotherapy affects the epithelial-mesenchymal transition of osteosarcoma cells, Invitrogen CDH2 antibody (Thermo Fisher, PA5-19486) was used in immunohistochemistry - paraffin section on human samples at 1:300, in immunocytochemistry on human samples at 1:200 (fig 1c) and in western blot on human samples at 1:1000 (fig 1e). Oncol Lett (2016) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; rat; loading ...; fig 7b
In order to describe a cardiovascular progenitor population derived during embryonic stem cell differentiation, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry on rat samples (fig 7b). Stem Cells Int (2016) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; mouse; loading ...; fig 3b
In order to show that decreased WNT/beta-catenin contributes to the pathophysiology of lamin A/C gene cardiomyopathy, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunocytochemistry on mouse samples (fig 3b). Hum Mol Genet (2017) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; mouse; loading ...
In order to discuss methods to generate induced cardiomyocytes in vitro and in vivo, Invitrogen CDH2 antibody (Thermo Fisher, 33-3900) was used in immunohistochemistry on mouse samples . Methods Mol Biol (2017) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; rat; 1:200; loading ...; fig 3a
  • western blot; rat; 1:200; loading ...; fig 3a
In order to explore how laminin2 in the basement membrane modulates the blood testis barrier dynamics during spermatogenesis, Invitrogen CDH2 antibody (ThermoFisher Scientific, 33-3900) was used in immunocytochemistry on rat samples at 1:200 (fig 3a) and in western blot on rat samples at 1:200 (fig 3a). FASEB J (2017) ncbi
mouse monoclonal (3B9)
  • western blot; human; loading ...; fig 4b
In order to investigate the role of Cx26 to cell mobility, Invitrogen CDH2 antibody (Thermo, 33-3900) was used in western blot on human samples (fig 4b). J Cell Sci (2016) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; human; loading ...; fig 3c
In order to show that apical polarization of the sodium, potassium-ATPase in retinal pigment epithelium cells depends on the expression of the beta2 subunit, Invitrogen CDH2 antibody (ZYMED, 333900) was used in immunocytochemistry on human samples (fig 3c). Front Physiol (2016) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; human; loading ...; fig 5c
  • western blot; human; loading ...; fig 5c
In order to investigate the alternative splicing of E-cadherin mRNA, Invitrogen CDH2 antibody (Zymed, 3-B9) was used in immunocytochemistry on human samples (fig 5c) and in western blot on human samples (fig 5c). J Cell Physiol (2017) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; rat; 1:100; loading ...; tbl 1
  • western blot; rat; 1:500; loading ...; tbl 1
In order to examine the organization of actin microfilaments in Sertoli cell at the blood testis barrier, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunocytochemistry on rat samples at 1:100 (tbl 1) and in western blot on rat samples at 1:500 (tbl 1). Spermatogenesis (2016) ncbi
mouse monoclonal (CH-19)
  • western blot; mouse; loading ...; fig 1a
In order to explore how ST8SIA2-mediated polysialylation influences oligodendrocyte differentiation and schizophrenia, Invitrogen CDH2 antibody (Thermo Scientific, MA1-91128) was used in western blot on mouse samples (fig 1a). Glia (2017) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; rat; 1:100; fig 1
  • western blot; rat; 1:500; fig 1
In order to characterize overexpression of gap junction protein connexin 43 by rescue of perfluorooctanesulfonate (PFOS)-mediated sertoli cell injury, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunocytochemistry on rat samples at 1:100 (fig 1) and in western blot on rat samples at 1:500 (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; loading ...
In order to identify signaling pathways that mediate the EGF-induced epithelial to mesenchymal transition, Invitrogen CDH2 antibody (Thermo Fisher, 33-3900) was used in immunohistochemistry on human samples . J Proteomics (2017) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; rat; 1:100; fig 2
  • immunocytochemistry; rat; 1:100; fig 5
  • western blot; rat; 1:200; fig 5
In order to report that crumbs homolog 3 is an actin microfilament regulator, Invitrogen CDH2 antibody (Invitrogen, Life Technologies, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100 (fig 2), in immunocytochemistry on rat samples at 1:100 (fig 5) and in western blot on rat samples at 1:200 (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; mouse; 1:200; fig s3
In order to study induction of granulosa cell fate and defects and cancers in mouse adult ovary by amplification of R-spondin1 signaling, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s3). Oncogene (2017) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to determine mediation of differentiation and cisplatin chemotherapy resistance by biased expression of the FOXP3delta3 isoform in aggressive bladder cancer, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Clin Cancer Res (2016) ncbi
mouse monoclonal (3B9)
  • immunoprecipitation; rat; 1:60; fig 2
  • immunocytochemistry; rat; 1:100; fig 1
  • western blot; rat; 1:200; fig 3
In order to determine regulation of ectoplasmic specialization dynamics via its effects on actin microfilaments in the testes of male rats by planar cell polarity (PCP) protein Vangl2, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunoprecipitation on rat samples at 1:60 (fig 2), in immunocytochemistry on rat samples at 1:100 (fig 1) and in western blot on rat samples at 1:200 (fig 3). Endocrinology (2016) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; rat; 1:100; fig 1
In order to characterize disruption of the sertolic cell cytoskeleton by interleukin 1alpha and its affect on gap junctional communication, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunocytochemistry on rat samples at 1:100 (fig 1). Cell Signal (2016) ncbi
mouse monoclonal (3B9)
  • western blot; mouse; 1:100; tbl 1
In order to elucidate a deletion of AMP-activated protein kinase in mouse Sertoli cells that modify germ cell quality, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in western blot on mouse samples at 1:100 (tbl 1). Mol Cell Endocrinol (2016) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 5
In order to investigate how CaSm promotes pancreatic cancer, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in western blot on human samples (fig 5). Oncogenesis (2016) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; rat; 1:100; tbl 2
In order to test if overexpression of Connexin 43 in adjudin-treated rats reseals the disrupted blood-testis barrier and reinitiates spermatogenesis, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100 (tbl 2). FASEB J (2016) ncbi
mouse monoclonal (3B9)
  • western blot; mouse; fig 7
In order to study postnatal liver maturation and its support by ESRP2 and adult splicing program in hepatocytes, Invitrogen CDH2 antibody (Life Technologies, 33?C3900) was used in western blot on mouse samples (fig 7). Nat Commun (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:150; fig 1b
In order to study markers of the epithelial to mesenchymal transition using invasive lobular carcinoma samples, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 1b). J Pathol (2016) ncbi
mouse monoclonal (3B9)
  • western blot; rat; 1:1000
  • western blot; African green monkey
In order to determine the functional effects of S368 phosphorylation of connexin 43, Invitrogen CDH2 antibody (Invitrogen, 33?C3900) was used in western blot on rat samples at 1:1000 and in western blot on African green monkey samples . J Cardiovasc Electrophysiol (2016) ncbi
mouse monoclonal (3B9)
  • western blot; human; 1:500; fig 2a
In order to characterize two clones from triple negative breast MDA-MB-231 cancer cells, Invitrogen CDH2 antibody (Invitrogene, 33-3900) was used in western blot on human samples at 1:500 (fig 2a). Exp Cell Res (2015) ncbi
mouse monoclonal (3B9)
  • western blot; human; 1:500; fig 3
In order to identify the role of defective autophagy in cerebral cavernous malformations, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in western blot on human samples at 1:500 (fig 3). EMBO Mol Med (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; mouse; 1:500
In order to test if Wwp1 regulates connexin 43, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry - frozen section on mouse samples at 1:500. J Mol Cell Cardiol (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse; 1:100; tbl 3
In order to characterize a conditional knock out of ataxia telangiectasia-mutated as a mouse model of pancreatic ductal adenocarcinoma, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (tbl 3). Nat Commun (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; equine; 1:500
  • western blot; equine; 1:500
In order to characterize the equine blood-testis barrier during tubular development in normal and cryptorchid stallions, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on equine samples at 1:500 and in western blot on equine samples at 1:500. Theriogenology (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; rat; 1:100
In order to study the role of plastin 3 in ectoplasmic specialization dynamics during spermatogenesis in the rat testis, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry on rat samples at 1:100. FASEB J (2015) ncbi
mouse monoclonal (3B9)
  • western blot; human; 1:1000
In order to elucidate the contribution of microRNAs in resistance to BRAF inhibitor treatment, Invitrogen CDH2 antibody (Life Technologies, 3B9) was used in western blot on human samples at 1:1000. Pigment Cell Melanoma Res (2015) ncbi
mouse monoclonal (3B9)
  • western blot; human; 1:500
In order to study the tissue factor protein and metastasis initiating cell markers during thrombocytosis, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in western blot on human samples at 1:500. BMC Cancer (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; rat; 1:100
  • immunoprecipitation; rat
  • western blot; rat; 1:1000
In order to study the effect of flutamide on the distribution of c-Src and the N-cadherin-beta-catenin complex in the seminiferous epithelium of adult rat, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on rat samples at 1:100, in immunoprecipitation on rat samples and in western blot on rat samples at 1:1000. Andrology (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; rat; 1:200
Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry on rat samples at 1:200. Exp Mol Pathol (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; rabbit; fig 4
  • western blot; rabbit; fig 3
In order to generate and characterize a novel rabbit corneal endothelial cell line, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry on rabbit samples (fig 4) and in western blot on rabbit samples (fig 3). J Tissue Eng Regen Med (2017) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; mouse
In order to investigate the role of fibroblast growth factor receptor 2 in corneal epithelial cell proliferation and differentiation during embryonic development, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry on mouse samples . PLoS ONE (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:300
Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:300. Hum Pathol (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:100. J Pathol (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; rat; 1:100
  • western blot; rat; 1:125
In order to investigate the role of rpS6 in blood-testis barrier function, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on rat samples at 1:100 and in western blot on rat samples at 1:125. J Cell Sci (2014) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; mouse; 1:200; fig s9a
In order to study the initiation and regulation of radial migration, Invitrogen CDH2 antibody (Invitrogen, 333900) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s9a). Nat Commun (2014) ncbi
mouse monoclonal (3B9)
  • western blot; rat; fig 6b
In order to study the role of calpain activation in hearts subjected to myocardial infarction, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in western blot on rat samples (fig 6b). J Biol Chem (2014) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 8a
In order to elucidate the critical role of TRPV2 in maintenance of cardiac function and structure in mice, Invitrogen CDH2 antibody (life technologies, 3B9) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 8a). Nat Commun (2014) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:500; fig 8
In order to study the contribution of 14-3-3gamma to testis organization and spermatogenesis, Invitrogen CDH2 antibody (Life Technologies, 33-3900) was used in immunohistochemistry on human samples at 1:500 (fig 8). J Cell Sci (2014) ncbi
mouse monoclonal (3B9)
  • western blot; human; 1:1000
In order to develop and characterize a novel three-dimensional cell culture model of ovarian endometriosis, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in western blot on human samples at 1:1000. J Ovarian Res (2014) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human
In order to evaluate the role of VEGF-mediated angiogenesis in EMT-induced cancer stemness and tumorigenesis, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on human samples . Cancer Res (2014) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:100; fig 9
In order to describe the magnetic levitation method of 3D cell culturing, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry on human samples at 1:100 (fig 9). Nat Protoc (2013) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 1
In order to describe the molecular pathologic characteristics of urothelial carcinomas subtypes, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). Am J Pathol (2013) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; rat; 1:100
In order to report that Rai14 regulates actin filaments organization in Sertoli cells during the epithelial cycle, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry on rat samples at 1:100. PLoS ONE (2013) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 4
In order to compare the histological, biological, and molecular features of 2D and 3D epithelial ovarian cancer cultures, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in western blot on human samples (fig 4). Lab Invest (2013) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:150; fig 1
In order to examine E-cadherin-negative ductal carcinoma, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry on human samples at 1:150 (fig 1). Histopathology (2013) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse
In order to study the development of fatal cardiac hypertrophy and arrrhythmia in mice overexpressing miRNA-17-92 in heart and smooth muscle, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on mouse samples . FASEB J (2013) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 3
In order to study the intercalated disc of the heart, Invitrogen CDH2 antibody (Invitrogen, clone 3B9) was used in western blot on human samples (fig 3). Dev Biol (2013) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 3
In order to investigate the role of miR-205 in human bladder cancers, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in western blot on human samples (fig 3). J Biol Chem (2013) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; rat; 1:100
In order to examine the role of actin and tubulin in ectoplasmic specialization, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100. Spermatogenesis (2012) ncbi
mouse monoclonal (3B9)
  • western blot; mouse; fig 4
In order to study plakoglobin using hypomorphic mice, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in western blot on mouse samples (fig 4). Genesis (2012) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; fig 3
In order to assess the incidence and prognostic significance of the epithelial to mesenchymal transition in cancer of unknown primary, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on human samples (fig 3). Anticancer Res (2012) ncbi
mouse monoclonal (3B9)
  • western blot; mouse; fig 1
In order to test if beta-catenin is required to maintain cardiac conduction in the absence of plakoglobin, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in western blot on mouse samples (fig 1). Mol Cell Biol (2012) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; mouse; fig 5
In order to test if CDH11 is increased in pulmonary fibrosis and contributes its development, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunocytochemistry on mouse samples (fig 5). FASEB J (2012) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse; 1:200
  • western blot; mouse
In order to study the role of the Rac1 GTPase the shaping of the ocular lens, Invitrogen CDH2 antibody (Invitrogen, 3b9) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 and in western blot on mouse samples . Dev Biol (2011) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:20
In order to test is c-met normalizes altered limbal stem cell marker patterns in diabetic corneas, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry on human samples at 1:20. Mol Vis (2011) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; human; 1:100; fig 4
In order to describe a method to cultivate corneal endothelial cells for transplantation, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunocytochemistry on human samples at 1:100 (fig 4). Tissue Eng Part A (2011) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:40; fig 5
In order to use adipose tissue-derived stem cells to generate dental buds, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on human samples at 1:40 (fig 5). Am J Pathol (2011) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; mouse; fig 6
In order to investigate how plakoglobin affects beta-catenin activity in the heart, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry on mouse samples (fig 6). Mol Cell Biol (2011) ncbi
mouse monoclonal (3B9)
  • western blot; human
In order to determine the role of mammary epithelial cell NF-kapaB signaling in tumor progression in vivo, Invitrogen CDH2 antibody (Zymed, 3B9) was used in western blot on human samples . Cancer Res (2010) ncbi
mouse monoclonal (3B9)
  • immunoprecipitation; rat; fig 2
In order to study the contribution of ZO-1 to cell-cell junction localization, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunoprecipitation on rat samples (fig 2). Am J Physiol Heart Circ Physiol (2011) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; mouse; fig 5
In order to study M-band alterations in heart disease, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry on mouse samples (fig 5). Basic Res Cardiol (2011) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; rat; 1:50; tbl 1
In order to test if the function of the blood-testis barrier in affected by adjudin, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunocytochemistry on rat samples at 1:50 (tbl 1). Int J Biochem Cell Biol (2010) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; rat; 1:50; tbl 1
  • western blot; rat; 1:250; tbl 1
In order to study protein trafficking in Sertoli cells, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunocytochemistry on rat samples at 1:50 (tbl 1) and in western blot on rat samples at 1:250 (tbl 1). Exp Cell Res (2010) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:100; tbl 1
In order to characterize the expression of a number of proteins in tissues from pseudomyxoma peritonei patients, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry on human samples at 1:100 (tbl 1). Hum Pathol (2010) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 2
In order to measure the expression of tenascin-C, osteopontin, and fibronectin in inflammatory myofibroblastic tumor of the lung, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). APMIS (2010) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; fig 3b
In order to examine granzyme B and perforin expression in bladder cancer cell lines and in urothelial carcinoma tissues, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry on human samples (fig 3b). Int J Cancer (2010) ncbi
mouse monoclonal (3B9)
  • western blot; human; 1:500; fig 6
In order to examine the effects of Slit2 expression on the migration and invasion of invasive glioma cells, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in western blot on human samples at 1:500 (fig 6). Neuro Oncol (2009) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 4
In order to measure expression of E-cadherin and related proteins in breast cancer cell lines, Invitrogen CDH2 antibody (Zymed, 3-B9) was used in western blot on human samples (fig 4). J Cell Physiol (2010) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 1
In order to determine the localization and function of N-cadherin in human spermatozoa and oocytes, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on human samples (fig 1). Int J Androl (2010) ncbi
mouse monoclonal (3B9)
  • western blot; mouse; fig 7
In order to observe the spatial expression of the mu-opioid receptor, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on mouse samples (fig 7). J Cell Mol Med (2009) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 3
In order to examine the effects of connexin-43 expression in breast cancer cells, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on human samples (fig 3). Clin Exp Metastasis (2008) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3b
  • western blot; human; 1:250; fig 5b
In order to assess if E- and N-cadherin expression has diagnostic value for intrahepatic cholangiocarcinoma, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3b) and in western blot on human samples at 1:250 (fig 5b). Mod Pathol (2009) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:200
In order to measure Twist and E- and N-cadherin expression in human primary bladder tumor from tobacco and non-tobacco users and evaluate their prognostic value, Invitrogen CDH2 antibody (Zymed Laboratories, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Urol Oncol (2009) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; mouse; fig 6
  • western blot; human; fig 3c
In order to examine cadherin expression in mouse fibroblast-like synoviocytes, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunocytochemistry on mouse samples (fig 6) and in western blot on human samples (fig 3c). Arthritis Rheum (2008) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; mouse; fig 3
In order to explore the relationship between N-cadherin and connexin43 in the heart, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry on mouse samples (fig 3). J Mol Cell Cardiol (2008) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; rat; fig 2
In order to examine the distribution of nectin-1 and afadin during hippocampal synapse formation, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunocytochemistry on rat samples (fig 2). J Comp Neurol (2008) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 6
In order to find that basic fibroblast growth factor downregulates typical cadherin expression on the surface of human umbilical vein endothelial cells via FGF receptor 1 signaling, Invitrogen CDH2 antibody (Zymed, 3B9) was used in western blot on human samples (fig 6). Exp Cell Res (2008) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 10
In order to propose that a paucity of pericytes in the germinal matrix vasculature contributes to its propensity to hemorrhage, Invitrogen CDH2 antibody (Zymed Laboratories, 33-3900) was used in western blot on human samples (fig 10). J Neurosci (2007) ncbi
mouse monoclonal (3B9)
  • western blot; rat; 0.1 ug/ml
In order to test if aconitine affects connexin43 phosphorylation and intracellular calcium oscillation patterns in cultured ventricular myocytes of neonatal rats, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on rat samples at 0.1 ug/ml. Toxicol In Vitro (2007) ncbi
mouse monoclonal (3B9)
  • western blot; mouse
In order to study epigenetic silencing and activation of the MOR gene, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on mouse samples . Mol Cell Biol (2007) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; rat; 1:50
In order to determine the distribution pattern and physiological function of coxsackie and adenovirus receptor in the testis, Invitrogen CDH2 antibody (Zymed Laboratories, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:50. Exp Cell Res (2007) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; mouse; 1:100; fig 2
In order to identify the membrane ruffle-targeting region of beta-catenin, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunocytochemistry on mouse samples at 1:100 (fig 2). J Biol Chem (2007) ncbi
mouse monoclonal (3B9)
  • western blot; mouse; 1:1000
In order to examine the effects of mammary gland-specific deletion of Bin1 on initiation and progression of breast cancer in mice, Invitrogen CDH2 antibody (Zymed, 3B9) was used in western blot on mouse samples at 1:1000. Cancer Res (2007) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; mouse
In order to compare the eye defects of dyl and Foxe3 mutant mice, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry on mouse samples . Dev Biol (2007) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; dog; 1:25; fig 5
In order to investigate genes regulated by Snail, Slug, and E47 transcription factors, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry on dog samples at 1:25 (fig 5). Cancer Res (2006) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discover if N-cadherin expression is associated with the bladder tumor progression, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Clin Cancer Res (2006) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 6
In order to report that Notch1 signaling drives the vertical growth phase of primary melanoma, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on human samples (fig 6). Cancer Res (2006) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; rat; tbl 1
  • immunoprecipitation; rat; tbl 1
  • western blot; rat; tbl 1
In order to determine the role of soluble guanylate cyclase in junction restructuring of the seminiferous epithelium of rat testis, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on rat samples (tbl 1), in immunoprecipitation on rat samples (tbl 1) and in western blot on rat samples (tbl 1). J Cell Physiol (2006) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; mouse; fig 4
  • western blot; mouse; fig 1
In order to identify and characterize a novel classical cadherin adhesion system, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunocytochemistry on mouse samples (fig 4) and in western blot on mouse samples (fig 1). J Cell Sci (2005) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; fig 5
  • western blot; human; fig 4
In order to study the intrinsic molecular programs that determine tumor differentiation, Invitrogen CDH2 antibody (Zymed Laboratories, 33-3900) was used in immunohistochemistry on human samples (fig 5) and in western blot on human samples (fig 4). J Pathol (2005) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human
In order to compare clinicopathological characteristics and immunohistochemical profiles of simultaneous bilateral breast cancer and corresponding lymph node metastases, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples . Histol Histopathol (2005) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; rat; 1:100; tbl 1
In order to test if TGF-beta3 regulates anchoring junction dynamics in the blood-testis barrier, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100 (tbl 1). Dev Biol (2005) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; rat; 1:100; tbl 1
In order to study regulation of the blood-testis barrier, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100 (tbl 1). J Cell Physiol (2005) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the effect of N-cadherin misexpression in mice, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on mouse samples . J Cell Biochem (2005) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 1
In order to measure the E- and N-cadherin and beta- and alpha-catenin expression in benign and malignant epithelial neoplasms of the ovary and correlate expression with tumor staging, histological grade, and presence of metastases during evolution, Invitrogen CDH2 antibody (ZYMED, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 1). Gynecol Oncol (2004) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 4
In order to test if carcinoma cells form gap junctions with bone cells and assess the function of this interaction, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on human samples (fig 4). Int J Cancer (2004) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:125; tbl 2
In order to report on a case of pilomatrix carcinoma with lymph node metastases, Invitrogen CDH2 antibody (ZYMED, 3B9) was used in immunohistochemistry on human samples at 1:125 (tbl 2). J Cutan Pathol (2004) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; rat; 1:100; fig 6
In order to investigate zyxin, axin, and Wiskott-Aldrich syndrome protein in the seminiferous epithelium, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 6). J Androl (2004) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to present three cases of primary peritoneal malignant mixed mullerian tumors, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Int J Gynecol Cancer (2003) ncbi
mouse monoclonal (3B9)
  • western blot; rat
In order to investigate the beta1-integrin/laminin gamma3 complex, MMP-2, MT1-MMP and TIMP-2 at the apical ectoplasmic specialization, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on rat samples . Biol Reprod (2004) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:20; fig 3
In order to study expression of E- and N-cadherin in mesotheliomas and adenocarcinomas, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry on human samples at 1:20 (fig 3). Hum Pathol (2003) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; mouse; 1:100
In order to test if N-cadherin is required for normal myocyte structure and function, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunocytochemistry on mouse samples at 1:100. J Cell Sci (2003) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; rat
In order to show that the cadherin/catenin complex is present between Sertoli and germ cells and is used for the assembly of functional adheren junctions, Invitrogen CDH2 antibody (Zymed, 33-3900,) was used in immunohistochemistry - frozen section on rat samples . Biol Reprod (2003) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:400; fig 1
In order to investigate the relationship between primary mucoepidermoid carcinoma of the thyroid and papillary thyroid carcinoma, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1). Virchows Arch (2002) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 2
  • western blot; mouse; 1:1000; fig 1
In order to explore the effect of cadherin specificity on cardiac structure and function, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2) and in western blot on mouse samples at 1:1000 (fig 1). J Cell Sci (2002) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 2
In order to investigate the expression of E-, N-, and P-cadherin in ductal carcinoma in situ of the breast, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 2). Virchows Arch (2002) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:200
In order to examine epithelial-type cadherin and neural-type cadherin as diagnostic markers of malignant noncarcinomatous neoplasms, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Arch Pathol Lab Med (2002) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to discuss using expression of cadherins and catenins as prognosis markers for cancer, Invitrogen CDH2 antibody (Zymed, clone 3B9) was used in immunohistochemistry - paraffin section on human samples (tbl 1). J Mammary Gland Biol Neoplasia (2001) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:400; fig 1
In order to describe the clinicopathological features of papillary thyroid carcinoma, Invitrogen CDH2 antibody (Zymed, clone 3B9) was used in immunohistochemistry on human samples at 1:400 (fig 1). J Pathol (2001) ncbi
mouse monoclonal (3B9)
  • western blot; human
In order to examine adhesion- versus a beta-catenin signaling-dependent mechanisms of E-cadherin tumor suppressor activity, Invitrogen CDH2 antibody (Zymed, 3B9) was used in western blot on human samples . J Cell Biol (2001) ncbi
mouse monoclonal (3B9)
  • immunoprecipitation; human
  • western blot; human
In order to assess the functional significance of N-cadherin in melanoma cells, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunoprecipitation on human samples and in western blot on human samples . Cancer Res (2001) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse; 1:100
In order to investigate the role of N-cadherin in cardiogenesis, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Development (2001) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse; 1:500
In order to study lens development in Pax6(Sey)(-1Neu)/+ mouse embryos, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on mouse samples at 1:500. Development (2000) ncbi
Articles Reviewed
  1. Gemel J, Su Z, Gileles Hillel A, Khalyfa A, Gozal D, Beyer E. Intermittent hypoxia causes NOX2-dependent remodeling of atrial connexins. BMC Cell Biol. 2017;18:7 pubmed publisher
  2. Fang S, Yu L, Mei H, Yang J, Gao T, Cheng A, et al. Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail. Oncol Lett. 2016;12:5007-5014 pubmed publisher
  3. Maltabe V, Barka E, Kontonika M, Florou D, Kouvara Pritsouli M, Roumpi M, et al. Isolation of an ES-Derived Cardiovascular Multipotent Cell Population Based on VE-Cadherin Promoter Activity. Stem Cells Int. 2016;2016:8305624 pubmed publisher
  4. Le Dour C, Macquart C, Sera F, Homma S, Bonne G, Morrow J, et al. Decreased WNT/?-catenin signalling contributes to the pathogenesis of dilated cardiomyopathy caused by mutations in the lamin a/C gene. Hum Mol Genet. 2017;26:333-343 pubmed publisher
  5. Ma H, Wang L, Liu J, Qian L. Direct Cardiac Reprogramming as a Novel Therapeutic Strategy for Treatment of Myocardial Infarction. Methods Mol Biol. 2017;1521:69-88 pubmed
  6. Gao Y, Mruk D, Chen H, Lui W, Lee W, Cheng C. Regulation of the blood-testis barrier by a local axis in the testis: role of laminin ?2 in the basement membrane. FASEB J. 2017;31:584-597 pubmed publisher
  7. Polusani S, Kalmykov E, Chandrasekhar A, Zucker S, Nicholson B. Cell coupling mediated by connexin 26 selectively contributes to reduced adhesivity and increased migration. J Cell Sci. 2016;129:4399-4410 pubmed
  8. Lobato Álvarez J, Roldán M, López Murillo T, González Ramírez R, Bonilla Delgado J, Shoshani L. The Apical Localization of Na+, K+-ATPase in Cultured Human Retinal Pigment Epithelial Cells Depends on Expression of the ?2 Subunit. Front Physiol. 2016;7:450 pubmed
  9. Matos M, Lapyckyj L, Rosso M, Besso M, Mencucci M, Briggiler C, et al. Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events. J Cell Physiol. 2017;232:1368-1386 pubmed publisher
  10. Li N, Lee W, Cheng C. Overexpression of plastin 3 in Sertoli cells disrupts actin microfilament bundle homeostasis and perturbs the tight junction barrier. Spermatogenesis. 2016;6:e1206353 pubmed publisher
  11. Szewczyk L, Brozko N, Nagalski A, Röckle I, Werneburg S, Hildebrandt H, et al. ST8SIA2 promotes oligodendrocyte differentiation and the integrity of myelin and axons. Glia. 2017;65:34-49 pubmed publisher
  12. Li N, Mruk D, Chen H, Wong C, Lee W, Cheng C. Rescue of perfluorooctanesulfonate (PFOS)-mediated Sertoli cell injury by overexpression of gap junction protein connexin 43. Sci Rep. 2016;6:29667 pubmed publisher
  13. Grassi M, Palma C, Thomé C, Lanfredi G, Poersch A, Faça V. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control. J Proteomics. 2017;151:2-11 pubmed publisher
  14. Gao Y, Lui W, Lee W, Cheng C. Polarity protein Crumbs homolog-3 (CRB3) regulates ectoplasmic specialization dynamics through its action on F-actin organization in Sertoli cells. Sci Rep. 2016;6:28589 pubmed publisher
  15. De Cian M, Pauper E, Bandiera R, Vidal V, Sacco S, Gregoire E, et al. Amplification of R-spondin1 signaling induces granulosa cell fate defects and cancers in mouse adult ovary. Oncogene. 2017;36:208-218 pubmed publisher
  16. Zhang H, Prado K, Zhang K, Peek E, Lee J, Wang X, et al. Biased Expression of the FOXP3?3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance. Clin Cancer Res. 2016;22:5349-5361 pubmed
  17. Chen H, Mruk D, Lee W, Cheng C. Planar Cell Polarity (PCP) Protein Vangl2 Regulates Ectoplasmic Specialization Dynamics via Its Effects on Actin Microfilaments in the Testes of Male Rats. Endocrinology. 2016;157:2140-59 pubmed publisher
  18. Chojnacka K, Bilinska B, Mruk D. Interleukin 1alpha-induced disruption of the Sertoli cell cytoskeleton affects gap junctional communication. Cell Signal. 2016;28:469-480 pubmed publisher
  19. Bertoldo M, Guibert E, Faure M, Guillou F, Ramé C, Nadal Desbarats L, et al. Specific deletion of AMP-activated protein kinase (α1AMPK) in mouse Sertoli cells modifies germ cell quality. Mol Cell Endocrinol. 2016;423:96-112 pubmed publisher
  20. Little E, Camp E, Wang C, Watson P, Watson D, Cole D. The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. Oncogenesis. 2016;5:e182 pubmed publisher
  21. Li N, Mruk D, Mok K, Li M, Wong C, Lee W, et al. Connexin 43 reboots meiosis and reseals blood-testis barrier following toxicant-mediated aspermatogenesis and barrier disruption. FASEB J. 2016;30:1436-52 pubmed publisher
  22. Bhate A, Parker D, Bebee T, Ahn J, Arif W, Rashan E, et al. ESRP2 controls an adult splicing programme in hepatocytes to support postnatal liver maturation. Nat Commun. 2015;6:8768 pubmed publisher
  23. McCart Reed A, Kutasovic J, Vargas A, Jayanthan J, Al Murrani A, Reid L, et al. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas. J Pathol. 2016;238:489-94 pubmed publisher
  24. Nassal M, Werdich A, Wan X, Hoshi M, Deschênes I, Rosenbaum D, et al. Phosphorylation at Connexin43 Serine-368 Is Necessary for Myocardial Conduction During Metabolic Stress. J Cardiovasc Electrophysiol. 2016;27:110-9 pubmed publisher
  25. Martínez Revollar G, Garay E, Martín Tapia D, Nava P, Huerta M, Lopez Bayghen E, et al. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Exp Cell Res. 2015;339:67-80 pubmed publisher
  26. Marchi S, Corricelli M, Trapani E, Bravi L, Pittaro A, Delle Monache S, et al. Defective autophagy is a key feature of cerebral cavernous malformations. EMBO Mol Med. 2015;7:1403-17 pubmed publisher
  27. Basheer W, Harris B, Mentrup H, Abreha M, Thames E, Lea J, et al. Cardiomyocyte-specific overexpression of the ubiquitin ligase Wwp1 contributes to reduction in Connexin 43 and arrhythmogenesis. J Mol Cell Cardiol. 2015;88:1-13 pubmed publisher
  28. Russell R, Perkhofer L, Liebau S, Lin Q, Lechel A, Feld F, et al. Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition. Nat Commun. 2015;6:7677 pubmed publisher
  29. Rode K, Sieme H, Richterich P, Brehm R. Characterization of the equine blood-testis barrier during tubular development in normal and cryptorchid stallions. Theriogenology. 2015;84:763-72 pubmed publisher
  30. Li N, Mruk D, Wong C, Lee W, Han D, Cheng C. Actin-bundling protein plastin 3 is a regulator of ectoplasmic specialization dynamics during spermatogenesis in the rat testis. FASEB J. 2015;29:3788-805 pubmed publisher
  31. Liu S, Tetzlaff M, Wang T, Yang R, Xie L, Zhang G, et al. miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment. Pigment Cell Melanoma Res. 2015;28:431-41 pubmed publisher
  32. ORELLANA R, Kato S, Erices R, Bravo M, Gonzalez P, Oliva B, et al. Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer. 2015;15:290 pubmed publisher
  33. Zarzycka M, Chojnacka K, Mruk D, Górowska E, Hejmej A, Kotula Balak M, et al. Flutamide alters the distribution of c-Src and affects the N-cadherin-β-catenin complex in the seminiferous epithelium of adult rat. Andrology. 2015;3:569-81 pubmed publisher
  34. Tennakoon A, Izawa T, Wijesundera K, Katou Ichikawa C, Tanaka M, Golbar H, et al. Analysis of glial fibrillary acidic protein (GFAP)-expressing ductular cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA). Exp Mol Pathol. 2015;98:476-85 pubmed publisher
  35. Kageyama T, Hayashi R, Hara S, Yoshikawa K, Ishikawa Y, Yamato M, et al. Spontaneous acquisition of infinite proliferative capacity by a rabbit corneal endothelial cell line with maintenance of phenotypic and physiological characteristics. J Tissue Eng Regen Med. 2017;11:1057-1064 pubmed publisher
  36. Zhang J, Upadhya D, Lu L, Reneker L. Fibroblast growth factor receptor 2 (FGFR2) is required for corneal epithelial cell proliferation and differentiation during embryonic development. PLoS ONE. 2015;10:e0117089 pubmed publisher
  37. Davidson B, Holth A, Hellesylt E, Tan T, Huang R, Tropé C, et al. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions. Hum Pathol. 2015;46:1-8 pubmed publisher
  38. Sun Y, Hu L, Zheng H, Bagnoli M, Guo Y, Rupaimoole R, et al. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer. J Pathol. 2015;235:25-36 pubmed publisher
  39. Mok K, Mruk D, Cheng C. rpS6 regulates blood-testis barrier dynamics through Akt-mediated effects on MMP-9. J Cell Sci. 2014;127:4870-82 pubmed publisher
  40. Ye T, Ip J, Fu A, Ip N. Cdk5-mediated phosphorylation of RapGEF2 controls neuronal migration in the developing cerebral cortex. Nat Commun. 2014;5:4826 pubmed publisher
  41. Kudo Sakamoto Y, Akazawa H, Ito K, Takano J, Yano M, Yabumoto C, et al. Calpain-dependent cleavage of N-cadherin is involved in the progression of post-myocardial infarction remodeling. J Biol Chem. 2014;289:19408-19 pubmed publisher
  42. Katanosaka Y, Iwasaki K, Ujihara Y, Takatsu S, Nishitsuji K, Kanagawa M, et al. TRPV2 is critical for the maintenance of cardiac structure and function in mice. Nat Commun. 2014;5:3932 pubmed publisher
  43. Sehgal L, Mukhopadhyay A, Rajan A, Khapare N, Sawant M, Vishal S, et al. 14-3-3?-Mediated transport of plakoglobin to the cell border is required for the initiation of desmosome assembly in vitro and in vivo. J Cell Sci. 2014;127:2174-88 pubmed publisher
  44. Brueggmann D, Templeman C, Starzinski Powitz A, Rao N, Gayther S, Lawrenson K. Novel three-dimensional in vitro models of ovarian endometriosis. J Ovarian Res. 2014;7:17 pubmed publisher
  45. Fantozzi A, Gruber D, Pisarsky L, Heck C, Kunita A, Yilmaz M, et al. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation. Cancer Res. 2014;74:1566-75 pubmed publisher
  46. Haisler W, Timm D, Gage J, Tseng H, Killian T, Souza G. Three-dimensional cell culturing by magnetic levitation. Nat Protoc. 2013;8:1940-9 pubmed publisher
  47. Sjödahl G, Lövgren K, Lauss M, Patschan O, Gudjonsson S, Chebil G, et al. Toward a molecular pathologic classification of urothelial carcinoma. Am J Pathol. 2013;183:681-91 pubmed publisher
  48. Qian X, Mruk D, Cheng C. Rai14 (retinoic acid induced protein 14) is involved in regulating f-actin dynamics at the ectoplasmic specialization in the rat testis*. PLoS ONE. 2013;8:e60656 pubmed publisher
  49. Lee J, Mhawech Fauceglia P, Lee N, Parsanian L, Lin Y, Gayther S, et al. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Lab Invest. 2013;93:528-42 pubmed publisher
  50. Rakha E, Teoh T, Lee A, Nolan C, Ellis I, Green A. Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study. Histopathology. 2013;62:695-701 pubmed publisher
  51. Danielson L, Park D, Rotllan N, Chamorro Jorganes A, Guijarro M, Fernandez Hernando C, et al. Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. FASEB J. 2013;27:1460-7 pubmed publisher
  52. Wang Q, Lin J, Chan S, Lin J. The Xin repeat-containing protein, mXin?, initiates the maturation of the intercalated discs during postnatal heart development. Dev Biol. 2013;374:264-80 pubmed publisher
  53. Tran M, Choi W, Wszolek M, Navai N, Lee I, Nitti G, et al. The p63 protein isoform ?Np63? inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. J Biol Chem. 2013;288:3275-88 pubmed publisher
  54. Tang E, Xiao X, Mruk D, Qian X, Mok K, Jenardhanan P, et al. Microtubule affinity-regulating kinase 4 (MARK4) is a component of the ectoplasmic specialization in the rat testis. Spermatogenesis. 2012;2:117-126 pubmed
  55. Swope D, Li J, Muller E, Radice G. Analysis of a Jup hypomorphic allele reveals a critical threshold for postnatal viability. Genesis. 2012;50:717-27 pubmed publisher
  56. Stoyianni A, Goussia A, Pentheroudakis G, Siozopoulou V, Ioachim E, Krikelis D, et al. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility. Anticancer Res. 2012;32:1273-81 pubmed
  57. Swope D, Cheng L, Gao E, Li J, Radice G. Loss of cadherin-binding proteins ?-catenin and plakoglobin in the heart leads to gap junction remodeling and arrhythmogenesis. Mol Cell Biol. 2012;32:1056-67 pubmed publisher
  58. Schneider D, Wu M, Le T, Cho S, Brenner M, Blackburn M, et al. Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-? production and epithelial to mesenchymal transition. FASEB J. 2012;26:503-12 pubmed publisher
  59. Maddala R, Chauhan B, Walker C, Zheng Y, Robinson M, Lang R, et al. Rac1 GTPase-deficient mouse lens exhibits defects in shape, suture formation, fiber cell migration and survival. Dev Biol. 2011;360:30-43 pubmed publisher
  60. Saghizadeh M, Soleymani S, Harounian A, Bhakta B, Troyanovsky S, Brunken W, et al. Alterations of epithelial stem cell marker patterns in human diabetic corneas and effects of c-met gene therapy. Mol Vis. 2011;17:2177-90 pubmed
  61. Watanabe R, Hayashi R, Kimura Y, Tanaka Y, Kageyama T, Hara S, et al. A novel gelatin hydrogel carrier sheet for corneal endothelial transplantation. Tissue Eng Part A. 2011;17:2213-9 pubmed publisher
  62. Ferro F, Spelat R, Falini G, Gallelli A, D Aurizio F, Puppato E, et al. Adipose tissue-derived stem cell in vitro differentiation in a three-dimensional dental bud structure. Am J Pathol. 2011;178:2299-310 pubmed publisher
  63. Li J, Swope D, Raess N, Cheng L, Muller E, Radice G. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling. Mol Cell Biol. 2011;31:1134-44 pubmed publisher
  64. Liu M, Sakamaki T, Casimiro M, Willmarth N, Quong A, Ju X, et al. The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer Res. 2010;70:10464-73 pubmed publisher
  65. Palatinus J, O Quinn M, Barker R, Harris B, Jourdan J, Gourdie R. ZO-1 determines adherens and gap junction localization at intercalated disks. Am J Physiol Heart Circ Physiol. 2011;300:H583-94 pubmed publisher
  66. Schoenauer R, Emmert M, Felley A, Ehler E, Brokopp C, Weber B, et al. EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy. Basic Res Cardiol. 2011;106:233-47 pubmed publisher
  67. Su L, Cheng C, Mruk D. Adjudin-mediated Sertoli-germ cell junction disassembly affects Sertoli cell barrier function in vitro and in vivo. Int J Biochem Cell Biol. 2010;42:1864-75 pubmed publisher
  68. Su L, Mruk D, Lee W, Cheng C. Differential effects of testosterone and TGF-?3 on endocytic vesicle-mediated protein trafficking events at the blood-testis barrier. Exp Cell Res. 2010;316:2945-60 pubmed publisher
  69. Flatmark K, Davidson B, Kristian A, Stavnes H, Førsund M, Reed W. Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models. Hum Pathol. 2010;41:1109-19 pubmed publisher
  70. Kaarteenaho R, Sormunen R, Paakko P. Variable expression of tenascin-C, osteopontin and fibronectin in inflammatory myofibroblastic tumour of the lung. APMIS. 2010;118:91-100 pubmed publisher
  71. D Eliseo D, Pisu P, Romano C, Tubaro A, De Nunzio C, Morrone S, et al. Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion. Int J Cancer. 2010;127:1283-94 pubmed publisher
  72. Yiin J, Hu B, Jarzynka M, Feng H, Liu K, Wu J, et al. Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity. Neuro Oncol. 2009;11:779-89 pubmed publisher
  73. Lapyckyj L, Castillo L, Matos M, Gabrielli N, Lüthy I, Vazquez Levin M. Expression analysis of epithelial cadherin and related proteins in IBH-6 and IBH-4 human breast cancer cell lines. J Cell Physiol. 2010;222:596-605 pubmed publisher
  74. Marín Briggiler C, Lapyckyj L, Gonzalez Echeverria M, Rawe V, Alvarez Sedó C, Vazquez Levin M. Neural cadherin is expressed in human gametes and participates in sperm-oocyte interaction events. Int J Androl. 2010;33:e228-39 pubmed publisher
  75. Hwang C, Song K, Kim C, Choi H, Guo X, Law P, et al. Epigenetic programming of mu-opioid receptor gene in mouse brain is regulated by MeCP2 and Brg1 chromatin remodelling factor. J Cell Mol Med. 2009;13:3591-615 pubmed publisher
  76. Li Z, Zhou Z, Welch D, Donahue H. Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clin Exp Metastasis. 2008;25:893-901 pubmed publisher
  77. Mosnier J, Kandel C, Cazals Hatem D, Bou Hanna C, Gournay J, Jarry A, et al. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas. Mod Pathol. 2009;22:182-90 pubmed publisher
  78. Fondrevelle M, Kantelip B, Reiter R, Chopin D, Thiery J, Monnien F, et al. The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status. Urol Oncol. 2009;27:268-76 pubmed publisher
  79. Agarwal S, Lee D, Kiener H, Brenner M. Coexpression of two mesenchymal cadherins, cadherin 11 and N-cadherin, on murine fibroblast-like synoviocytes. Arthritis Rheum. 2008;58:1044-54 pubmed publisher
  80. Li J, Levin M, Xiong Y, Petrenko N, Patel V, Radice G. N-cadherin haploinsufficiency affects cardiac gap junctions and arrhythmic susceptibility. J Mol Cell Cardiol. 2008;44:597-606 pubmed publisher
  81. Lim S, Lim K, Giuliano R, Federoff H. Temporal and spatial localization of nectin-1 and l-afadin during synaptogenesis in hippocampal neurons. J Comp Neurol. 2008;507:1228-44 pubmed publisher
  82. Wu J, Yan H, Chen W, Chen W, Wang C, Chi Y, et al. JNK signaling pathway is required for bFGF-mediated surface cadherin downregulation on HUVEC. Exp Cell Res. 2008;314:421-9 pubmed publisher
  83. Braun A, Xu H, Hu F, Kocherlakota P, Siegel D, Chander P, et al. Paucity of pericytes in germinal matrix vasculature of premature infants. J Neurosci. 2007;27:12012-24 pubmed
  84. Zhang S, Liu Y, Huang G, Liu L. Aconitine alters connexin43 phosphorylation status and [Ca2+] oscillation patterns in cultured ventricular myocytes of neonatal rats. Toxicol In Vitro. 2007;21:1476-85 pubmed
  85. Hwang C, Song K, Kim C, Choi H, Guo X, Law P, et al. Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters. Mol Cell Biol. 2007;27:4720-36 pubmed
  86. Wang C, Mruk D, Lee W, Cheng C. Coxsackie and adenovirus receptor (CAR) is a product of Sertoli and germ cells in rat testes which is localized at the Sertoli-Sertoli and Sertoli-germ cell interface. Exp Cell Res. 2007;313:1373-92 pubmed
  87. Sharma M, Henderson B. IQ-domain GTPase-activating protein 1 regulates beta-catenin at membrane ruffles and its role in macropinocytosis of N-cadherin and adenomatous polyposis coli. J Biol Chem. 2007;282:8545-56 pubmed
  88. Chang M, Boulden J, Sutanto Ward E, DuHadaway J, Soler A, Muller A, et al. Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression. Cancer Res. 2007;67:100-7 pubmed
  89. Blixt A, Landgren H, Johansson B, Carlsson P. Foxe3 is required for morphogenesis and differentiation of the anterior segment of the eye and is sensitive to Pax6 gene dosage. Dev Biol. 2007;302:218-29 pubmed
  90. Moreno Bueno G, Cubillo E, Sarrio D, Peinado H, Rodriguez Pinilla S, Villa S, et al. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res. 2006;66:9543-56 pubmed
  91. Lascombe I, Clairotte A, Fauconnet S, Bernardini S, Wallerand H, Kantelip B, et al. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin Cancer Res. 2006;12:2780-7 pubmed
  92. Liu Z, Xiao M, Balint K, Smalley K, Brafford P, Qiu R, et al. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res. 2006;66:4182-90 pubmed
  93. Sarkar O, Xia W, Mruk D. Adjudin-mediated junction restructuring in the seminiferous epithelium leads to displacement of soluble guanylate cyclase from adherens junctions. J Cell Physiol. 2006;208:175-87 pubmed
  94. Kim Y, Sauer C, Testa K, Wahl J, Svoboda R, Johnson K, et al. Modulating the strength of cadherin adhesion: evidence for a novel adhesion complex. J Cell Sci. 2005;118:3883-94 pubmed
  95. Sun X, Wei L, Liden J, Hui G, Dahlman Wright K, Hjerpe A, et al. Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling. J Pathol. 2005;207:91-101 pubmed
  96. Bassarova A, Torlakovic E, Sedloev T, Hristova S, Trifonov D, Nesland J. Simultaneous bilateral breast carcinoma: Histopathological characteristics and CD44/catenin-cadherin profile. Histol Histopathol. 2005;20:791-9 pubmed publisher
  97. Xia W, Cheng C. TGF-beta3 regulates anchoring junction dynamics in the seminiferous epithelium of the rat testis via the Ras/ERK signaling pathway: An in vivo study. Dev Biol. 2005;280:321-43 pubmed
  98. Xia W, Wong C, Lee N, Lee W, Cheng C. Disruption of Sertoli-germ cell adhesion function in the seminiferous epithelium of the rat testis can be limited to adherens junctions without affecting the blood-testis barrier integrity: an in vivo study using an androgen suppression model. J Cell Physiol. 2005;205:141-57 pubmed
  99. Knudsen K, Sauer C, Johnson K, Wheelock M. Effect of N-cadherin misexpression by the mammary epithelium in mice. J Cell Biochem. 2005;95:1093-107 pubmed
  100. Marques F, Fonsechi Carvasan G, de Angelo Andrade L, Bottcher Luiz F. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Gynecol Oncol. 2004;94:16-24 pubmed
  101. Kapoor P, Saunders M, Li Z, Zhou Z, Sheaffer N, Kunze E, et al. Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. Int J Cancer. 2004;111:693-7 pubmed
  102. Bassarova A, Nesland J, Sedloev T, Danielsen H, Christova S. Pilomatrix carcinoma with lymph node metastases. J Cutan Pathol. 2004;31:330-5 pubmed
  103. Lee N, Mruk D, Conway A, Cheng C. Zyxin, axin, and Wiskott-Aldrich syndrome protein are adaptors that link the cadherin/catenin protein complex to the cytoskeleton at adherens junctions in the seminiferous epithelium of the rat testis. J Androl. 2004;25:200-15 pubmed
  104. Ng J, Han A, Edelson M, Rosenblum N. Oncoprotein profiles of primary peritoneal malignant mixed müllerian tumors. Int J Gynecol Cancer. 2003;13:870-4 pubmed
  105. Siu M, Cheng C. Interactions of proteases, protease inhibitors, and the beta1 integrin/laminin gamma3 protein complex in the regulation of ectoplasmic specialization dynamics in the rat testis. Biol Reprod. 2004;70:945-64 pubmed
  106. Ordonez N. Value of E-cadherin and N-cadherin immunostaining in the diagnosis of mesothelioma. Hum Pathol. 2003;34:749-55 pubmed
  107. Luo Y, Radice G. Cadherin-mediated adhesion is essential for myofibril continuity across the plasma membrane but not for assembly of the contractile apparatus. J Cell Sci. 2003;116:1471-9 pubmed
  108. Lee N, Mruk D, Lee W, Cheng C. Is the cadherin/catenin complex a functional unit of cell-cell actin-based adherens junctions in the rat testis?. Biol Reprod. 2003;68:489-508 pubmed
  109. Rocha A, Soares P, Machado J, Máximo V, Fonseca E, Franssila K, et al. Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex. Virchows Arch. 2002;440:498-504 pubmed
  110. Ferreira Cornwell M, Luo Y, Narula N, Lenox J, Lieberman M, Radice G. Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart. J Cell Sci. 2002;115:1623-34 pubmed
  111. Paredes J, Milanezi F, Viegas L, Amendoeira I, Schmitt F. P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast. Virchows Arch. 2002;440:16-21 pubmed
  112. Laskin W, Miettinen M. Epithelial-type and neural-type cadherin expression in malignant noncarcinomatous neoplasms with epithelioid features that involve the soft tissues. Arch Pathol Lab Med. 2002;126:425-31 pubmed
  113. Wheelock M, Soler A, Knudsen K. Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia. 2001;6:275-85 pubmed
  114. Rocha A, Soares P, Seruca R, Máximo V, Matias Guiu X, Cameselle Teijeiro J, et al. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J Pathol. 2001;194:358-66 pubmed
  115. Gottardi C, Wong E, Gumbiner B. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol. 2001;153:1049-60 pubmed
  116. Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 2001;61:3819-25 pubmed
  117. Luo Y, Ferreira Cornwell M, Baldwin H, Kostetskii I, Lenox J, Lieberman M, et al. Rescuing the N-cadherin knockout by cardiac-specific expression of N- or E-cadherin. Development. 2001;128:459-69 pubmed
  118. van Raamsdonk C, Tilghman S. Dosage requirement and allelic expression of PAX6 during lens placode formation. Development. 2000;127:5439-48 pubmed